Interleukin-23 Antagonists [MoA] - N0000192798
Pharmacologic Class Information
Pharmacologic Code | N0000192798 |
Pharmacologic Name | Interleukin-23 Antagonists |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Interleukin-23 Antagonists
The following table contains 8 products whose active ingredient are classified under the same pharmacologic class Interleukin-23 Antagonists [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0074-1050 | Skyrizi | Non-Proprietary Name: Risankizumab-rzaa | Injection | Subcutaneous | Abbvie Inc. | ACTIVE | |
0074-2100 | Skyrizi | Non-Proprietary Name: Risankizumab-rzaa | Injection | Subcutaneous | Abbvie Inc. | ACTIVE | |
0074-5015 | Skyrizi | Non-Proprietary Name: Risankizumab-rzaa | Injection | Intravenous | Abbvie Inc. | ACTIVE | |
47335-177 | Ilumya | Non-Proprietary Name: Tildrakizumab-asmn | Injection, Solution | Subcutaneous | Sun Pharmaceutical Industries, Inc. | ACTIVE | |
57894-054 | Stelara | Non-Proprietary Name: Ustekinumab | Solution | Intravenous | Janssen Biotech, Inc. | ACTIVE | |
57894-060 | Stelara | Non-Proprietary Name: Ustekinumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
57894-061 | Stelara | Non-Proprietary Name: Ustekinumab | Injection, Solution | Subcutaneous | Janssen Biotech, Inc. | ACTIVE | |
57894-640 | Tremfya | Non-Proprietary Name: Guselkumab | Injection | Subcutaneous | Janssen Biotech, Inc. | ACTIVE |